Login / Signup
Weronika Kuryło
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 4
Top Topics
Regulatory T Cells
Healthcare
Ejection Fraction
End Stage Renal Disease
Top Venues
Cancers
International journal of molecular sciences
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Anna Pawłowska-Łachut
,
Anna K Rekowska
,
Weronika Kuryło
,
Anna Pańczyszyn
,
Jan Kotarski
,
Iwona Wertel
Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors.
International journal of molecular sciences
24 (13) (2023)
Anna Pawłowska-Łachut
,
Wiktoria Skiba
,
Dorota Suszczyk
,
Weronika Kuryło
,
Joanna Jakubowicz-Gil
,
Roman Paduch
,
Iwona Wertel
The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients.
Cancers
14 (23) (2022)
Anna Pawłowska-Łachut
,
Wiktoria Skiba
,
Dorota Suszczyk
,
Weronika Kuryło
,
Joanna Jakubowicz-Gil
,
Roman Paduch
,
Iwona Wertel
The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients.
Cancers
14 (23) (2022)
Anna Pawłowska-Łachut
,
Wiktoria Skiba
,
Dorota Suszczyk
,
Weronika Kuryło
,
Joanna Jakubowicz-Gil
,
Roman Paduch
,
Iwona Wertel
The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients.
Cancers
14 (23) (2022)